QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

Los Angeles, CA -- (SBWire) -- 02/01/2019 --Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.

The global average price of Perphenazine is in the decreasing trend, from 6.95 USD/Unit in 2012 to 7.08 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.

The classification of Perphenazine includes Oral Forms and Injectable Solution, and the proportion of Oral Forms in 2016 is about 98%.

The global Perphenazine market is valued at 95 million US$ in 2018 is expected to reach 100 million US$ by the end of 2025, growing at a CAGR of 0.6% during 2019-2025.

Perphenazine is widely used to treat psychosis and antiemetic. The most proportion of Perphenazine is used to treat psychosis, and the proportion in 2016 is 95%.

North America is the largest consumption place, with a consumption market share nearly 39% in 2015. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.

Market competition is not intense. Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.

Get PDF report template @

https://www.qyresearch.com/sample-form/form/949069/global-perphenazine-competition-forecast-amp%3B-opportunities

This report focuses on Perphenazine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Perphenazine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

    Teva

    Sandoz

    Endo

    Mylan

    ZHPHARMA

    Shandong Boshan Pharma

    ...

Segment by Regions

    North America

    Europe

    China

    Japan

Segment by Type

    Oral Forms

    Injectable Solution

Segment by Application

    Psychosis

    Antiemetic

Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report

Get Complete Report in your Inbox within 24 hours @ 
https://www.qyresearch.com/request-discount/form/949069/global-perphenazine-competition-forecast-amp%3B-opportunities
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.